We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$392M
AUM Growth
+$56.2M
Cap. Flow
-$2.88M
Cap. Flow %
-0.74%
Top 10 Hldgs %
41.75%
Holding
71
New
2
Increased
15
Reduced
38
Closed
6

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$13.7M
2
VMC icon
Vulcan Materials
VMC
+$3.22M
3
VMW
VMware, Inc
VMW
+$2.7M
4
SH icon
ProShares Short S&P500
SH
+$2.26M
5
USB icon
US Bancorp
USB
+$1.87M

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$12.3M
2
TFC icon
Truist Financial
TFC
+$3.81M
3
MLM icon
Martin Marietta Materials
MLM
+$3.38M
4
LKQ icon
LKQ Corp
LKQ
+$2.61M
5
INTC icon
Intel
INTC
+$815K

Sector Composition

Rank Sector Weight
1 Healthcare 33.39%
2 Technology 27.36%
3 Industrials 11.52%
4 Financials 7.14%
5 Materials 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$28.1M 7.17%
307,792
-10,136
-3% -$785K
INTC icon
2
Intel
INTC
$473B
$23M 5.88%
384,913
-13,625
-3% -$815K
ECL icon
3
Ecolab
ECL
$80.4B
$16.3M 4.17%
82,015
-166
-0.2% -$32.1K
SYK icon
4
Stryker
SYK
$127B
$15.2M 3.88%
84,414
-256
-0.3% -$47.2K
RTX icon
5
RTX Corp
RTX
$285B
$14.1M 3.61%
229,211
+219,024
+2,150% +$13.7M
TMO icon
6
Thermo Fisher Scientific
TMO
$230B
$14M 3.57%
38,550
-2,187
-5% -$733K
JPM icon
7
JPMorgan Chase
JPM
$951B
$13.6M 3.48%
145,017
+9,923
+7% +$941K
JNJ icon
8
Johnson & Johnson
JNJ
$646B
$13.6M 3.47%
96,678
-1,304
-1% -$190K
MSFT icon
9
Microsoft
MSFT
$3.81T
$13.1M 3.36%
64,594
-285
-0.4% -$51.7K
MRK icon
10
Merck
MRK
$366B
$12.4M 3.17%
168,086
-1,098
-0.6% -$82.7K
PAYX icon
11
Paychex
PAYX
$45.2B
$11.8M 3.01%
155,637
-1,168
-0.7% -$81K
ALC icon
12
Alcon
ALC
$34.8B
$11.2M 2.85%
194,656
-6,648
-3% -$376K
VAR
13
DELISTED
Varian Medical Systems, Inc.
VAR
$10.9M 2.78%
88,843
-555
-0.6% -$64.3K
VMW
14
DELISTED
VMware, Inc
VMW
$10.4M 2.65%
67,129
+19,666
+41% +$2.7M
ABBV icon
15
AbbVie
ABBV
$451B
$10.2M 2.6%
103,599
-3,049
-3% -$268K
VMC icon
16
Vulcan Materials
VMC
$35.6B
$9.79M 2.5%
84,470
+29,441
+54% +$3.22M
CSCO icon
17
Cisco
CSCO
$433B
$9.57M 2.44%
205,178
-61
-0% -$2.67K
STE icon
18
Steris
STE
$22.8B
$8.91M 2.28%
58,088
-15
-0% -$2.29K
CPRT icon
19
Copart
CPRT
$30.5B
$8.76M 2.24%
420,636
-26,400
-6% -$530K
CHD icon
20
Church & Dwight Co
CHD
$24B
$8.41M 2.15%
108,831
+1,746
+2% +$127K
NVS icon
21
Novartis
NVS
$292B
$8.14M 2.08%
93,250
-5,784
-6% -$499K
HOLX
22
DELISTED
Hologic
HOLX
$7.5M 1.91%
131,530
-4,590
-3% -$225K
WWD icon
23
Woodward
WWD
$20.2B
$7.42M 1.89%
95,693
-1,220
-1% -$79.7K
WSO icon
24
Watsco Inc
WSO
$12.8B
$7M 1.79%
39,410
-1,019
-3% -$169K
RMD icon
25
ResMed
RMD
$34.7B
$6.7M 1.71%
34,868
-1,690
-5% -$277K

Similar funds

LaFleur & Godfrey's Q2 2020 Portfolio in Review

As of Q2 2020, LaFleur & Godfrey held 71 positions worth $392M, up 17% from $336M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

LaFleur & Godfrey's Q2 2020 filing shows 2 new, 15 increased, 38 reduced and 6 closed positions. Its largest new stake was ProShares Short S&P500: 23,488 shares worth $2.1M. The largest sale was Raytheon Company, an estimated $12.3M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.

  • LaFleur & Godfrey's largest Q2 2020 buy was ProShares Short S&P500: 23,488 shares worth $2.1M.
  • LaFleur & Godfrey added most to RTX Corp in Q2 2020, an estimated $13.7M increase.
  • LaFleur & Godfrey's biggest Q2 2020 reduction was Truist Financial, cutting an estimated $3.81M.
  • LaFleur & Godfrey fully exited Raytheon Company in Q2 2020, selling an estimated $12.3M.
  • LaFleur & Godfrey's ten largest holdings make up 42% of its $392M portfolio in Q2 2020.
  • LaFleur & Godfrey opened 2 new positions and closed 6 in Q2 2020.
  • LaFleur & Godfrey's portfolio value rose 17% quarter-over-quarter to $392M.

Based on LaFleur & Godfrey's 13F filing for Q2 2020, filed 28 Jul 2020.